➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Colorcon
AstraZeneca
McKinsey
Johnson and Johnson

Last Updated: November 26, 2020

DrugPatentWatch Database Preview

Claims for Patent: 5,795,911

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 5,795,911
Title: Composition for treating Condyloma acuminata
Abstract:A composition for a treatment of HPV-infected Condyloma acuminata which comprises containing tea catechin as a main component. This medication has no danger of side-effects and may be easily applied to or inserted in the infected area by the patient themselves.
Inventor(s): Cheng; Shu Jun (Beijing, CN), Wang; De Chang (Beijing, CN), Hara; Yukihiko (Fujieda, JP)
Assignee: Cancer Institute (Hospital), Chinese Academy of Medical Sciences (Beijing, CN) Mitsui Norin Co., Ltd. (Tokyo, JP)
Application Number:08/835,920
Patent Claims: 1. A method of treating Condyloma acuminata caused by human papillomavirus, comprising applying to an infected area on a human a composition which comprises a tea catechin as a main component in an amount effective for treating Condyloma acuminata.

2. The method according to claim 1, wherein the composition is in the form of an ointment or a suppository.

3. The method according to claim 1, wherein said composition is in the form of an ointment having 5-20% by weight of tea catechin.

4. The method according to claim 1, wherein said composition is in the form of a suppository having 100-500 mg of the tea catechin in a capsule.

5. The method according to claim 1, wherein said tea catechin comprises (-)-epigallocatechin.

6. The method according to claim 3, wherein the tea catechin is in an amount of 12-18% by weight.

7. The method according to claim 4, wherein the tea catechin is in an amount of 15% by weight.

8. The method according to claim 3, wherein the capsule contains 200-300 mg of the tea catechin.

9. The method according to claim 4, wherein the capsule contains 250 mg of the tea catechin.

10. The method according to claim 3, wherein the ointment contains vaseline as a base to form a cream.

11. The method according to claim 3, wherein the ointment is applied to external genital organs.

12. The method according to claim 4, wherein the suppository is applied to the vagina of a human.

13. The method according to claim 1, wherein the infected area is the vagina.

14. The method according to claim 1, wherein the infected area is an external genital organ.

15. The method according to claim 1, wherein the infected area is the cervix.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Colorcon
Medtronic
Dow
Boehringer Ingelheim
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.